Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Synthesis and structure-activity relationships of 2-pyridones: II. 8-(Fluoro-substituted pyrrolidinyl)-2-pyridones as antibacterial agentsQ Li, W Wang, K B Berst, et al.Journal of Medicinal Chemistry|August 28, 1998
Synthesis of 9-deoxo-4''-deoxy-6,9-epoxyerythromycin derivatives: novel and acid-stable motilidesR Faghih, P A Lartey, H N Nellans, et al.Journal of Medicinal Chemistry|May 30, 1998
Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analoguesR L Elliott, D Pireh, G Griesgraber, et al.Bioorganic & Medicinal Chemistry Letters|July 11, 2000
Antifungal rapamycin analogues with reduced immunosuppressive activityD A Dickman, H Ding, Q Li, et al.Antimicrobial Agents and Chemotherapy|March 1, 1997
Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavirD J Kempf, K C Marsh, G Kumar, et al.Biochemical and Biophysical Research Communications|August 14, 1996
Novel azacyclic ureas that are potent inhibitors of HIV-1 proteaseH L Sham, C Zhao, K C Marsh, et al.Journal of Medicinal Chemistry|March 4, 1998
Discovery of ritonavir, a potent inhibitor of HIV protease with high oral bioavailability and clinical efficacyD J Kempf, H L Sham, K C Marsh, et al.Bioorganic & Medicinal Chemistry|September 8, 2000
Total synthesis and antifungal evaluation of cyclic aminohexapeptidesL L Klein, L Li, H J Chen, et al.Journal of Medicinal Chemistry|January 19, 1996
A novel, picomolar inhibitor of human immunodeficiency virus type 1 proteaseH L Sham, C Zhao, K D Stewart, et al.Journal of Medicinal Chemistry|August 2, 1996
Synthesis and structure-activity relationships of 2-pyridones: a novel series of potent DNA gyrase inhibitors as antibacterial agentsQ Li, D T Chu, A Claiborne, et al.Pageof 7